lecozotan

Known as: 4-Cyano-N-(2R-(4-(2,3-dihydrobenzo(1,4)-dioxin-5-yl)-piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2012
012320052012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
There is a potential risk that 5-HT(1A) receptor blockade combined with blockade of the 5-HT transporter by an SSRI may cause a… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2010
2010
Lecozotan is a selective serotonergic 5-HT(1A) receptor antagonist previously shown to enhance task performance efficiency in… (More)
Is this relevant?
2009
2009
AIMS To determine the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of oral immediate release (IR) lecozotan in healthy… (More)
Is this relevant?
2008
2008
This positron emission tomography (PET) study was conducted to assess binding of lecozotan, a new potent and silent 5… (More)
Is this relevant?
2005
2005
Recent data has suggested that the 5-hydroxytryptamine (5-HT)(1A) receptor is involved in cognitive processing. A novel 5-HT(1A… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2005
2005
A series of benzodioxanylpiperazine derivatives possessing a 4-aryl amide substituent was prepared and evaluated for 5-HT(1A… (More)
Is this relevant?
2005
2005
Recent data has suggested that the 5-HT1A receptor is involved in cognitive processing. A novel 5-HT1A receptor antagonist, 4… (More)
  • table 2
Is this relevant?